DR. CLAIRE COCKCROFT, THE BABRAHAM INSTITUTE, CAMBRIDGE, UK, JOINS CSG ADVISORY BOARD
Boston, May 1, 2013 – The Communications Strategy Group Inc., (CSG) announced today that Dr. Claire
Cockcroft, a highly recognized scientist, innovator and senior communications professional at the
Babraham Institute, Cambridge, UK, has joined the firm’s Advisory Board.
In her capacity as Head, External Relations, Dr. Cockcroft’s responsibilities include
corporate communications, public affairs, public relations and marketing including Babraham’s dynamic
bioincubator programme. Dr. Cockcroft earned a degree in biochemistry from Oxford and PhD in plant
molecular biology from the University of Cambridge.
While a post-doctoral researcher at Cambridge Dr. Cockcroft was awarded a Media Fellowship by the
British Association of Science. Among other initiatives, she pioneered the development of a crossdisciplinary Masters Programme at Cambridge with the Massachusetts Institute of Technology, Boston.
Aimed at aspiring bio-entrepreneurs and future leaders of the life science sector, the Bioscience
Enterprise Programme is now internationally recognized as an example of excellence in crossdisciplinary post-graduate training.
Dr. Cockcroft joined the Babraham Institute in 2005 where, in addition to handling external relations,
she established a widely acclaimed Science & Society Programme, delivering many novel science
enrichment activities for schools including a 6th form summer Bioscience BootCamp, 6th form
conferences, careers events, workshops exploring the scientific and ethical issues of research with
animals. She has also established summer research programmes for 6th formers and undergraduates.
Ted Agne, CSG’s president said, “We’re delighted and fortunate to have Claire Cockcroft, an experienced
and highly respected life sciences and communications professional, as part of our team. We have had
the pleasure of knowing and working with her for several years and have always found her advice and
counsel to be of great value. Her contributions to the life sciences, innovation and forward thinking are
beyond measure.”
About the Babraham Institute
The Babraham Institute undertakes innovative, life sciences research to generate new knowledge of
biological mechanisms underpinning lifelong health and well being. Research focuses on signalling and
genome regulation, particularly the interplay between the two, and how epigenetic signals can influence
important physiological adaptations during the lifespan of an organism. By determining how the body
reacts to dietary and environmental stimuli, and manages microbial and viral challenges, we aim to
improve lifelong well being and healthier ageing.
A European and world leader in this area, the Institute is recognised for its pioneering research
investigating the principles of epigenetic gene regulation in early development, particularly in germ cells,
stem cells and early lineage decisions and in the fundamental regulation of the genome. Babraham's
research is recognised as internationally-competitive and maintains unique research facilities of national
importance.
The Babraham Institute is a registered charity, which receives funding from the Biotechnology and
Biological Sciences Research Council (BBSRC). Research investigating the medical importance of the
biological mechanisms underpinning lifelong health is also supported by grants awarded by theMedical
Research Council (MRC), as well as many other organisations and charities. The Institute’s research
supports BBSRC's mission to drive advances in fundamental bioscience to underpin pharmaceuticals,
health and well being during ageing, and to benefit industrial wealth creation in the UK.
About The Communications Strategy Group Inc.
Founded in 1987, CSG is a US-based international consultancy providing corporate/financial relations
and business development services to the life sciences, biotechnology, medical device and advanced
technology sectors. The firm specialises in working with UK and EU companies seeking to boost their
global recognition. CSG is partnered with Cabinet Privé de Conseil SA, Geneva and College Hill Life
Sciences, London.